État actuel : Annulée

Cette norme a été révisée par ISO/TR 12417-2:2022

Résumé

ISO/TR 12417-2:2017 provides region-specific information for

- local submissions and approvals for vascular device-drug combination products (VDDCPs) in countries and regions around the world;

- changes related to the drug containing part and how they are evaluated by the different local regions.

For implanted products, this document is considered as a supplement to ISO 14630, which specifies general requirements for the performance of non-active surgical implants.

ISO/TR 12417-2:2017 is considered also as a supplement to ISO 12417‑1, and any relevant device-specific standards, such as the ISO 25539 series specifying requirements for endovascular devices. Requirements listed in this document also address VDDCPs that are not necessarily permanent implants.

Informations générales

  • État actuel
     : Annulée
    Date de publication
     : 2017-11
    Stade
    : Annulation de la Norme internationale [95.99]
  • Edition
     : 1
  • Comité technique :
    ISO/TC 150/SC 2
    ICS :
    11.040.40 
  • RSS mises à jour

Cycle de vie

Vous avez une question?

Consulter notre FAQ

Service à la clientèle
+41 22 749 08 88

Horaires d’ouverture:
De lundi à vendredi - 09:00-12:00, 14:00-17:00 (UTC+1)

  2. Store
  3. Catalogue de normes
  4. TC
  5. ISO/TC 150/SC 2
  6. ISO/TR 12417-2:2017